Annual report pursuant to Section 13 and 15(d)

ACCRUED EXPENSES (Tables)

v3.20.4
ACCRUED EXPENSES (Tables)
12 Months Ended
Dec. 31, 2020
Payables and Accruals [Abstract]  
SCHEDULE OF ACCRUED EXPENSES

Accrued expenses consisted of the following: 

 

    2020     2019  
    December 31,  
    2020     2019  
Accrued clinical operations and trials costs   $ 14,132,842     $ 14,242,669  
Accrued product development costs     2,189,047       3,573,231  
Accrued compensation     4,222,594       3,673,111  
Accrued other     1,460,949       958,928  
Total   $ 22,005,432     $ 22,447,939